Doman Robert F 4
4 · Echo Therapeutics, Inc. · Filed Apr 10, 2013
Insider Transaction Report
Form 4
Doman Robert F
Director
Transactions
- Award
Common Stock
2013-04-09+4,000→ 39,000 total
Footnotes (1)
- [F1]The shares vest on April 9, 2014, provided, however that all unvested Restricted Shares shall immediately vest upon the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. As used herein, "Liquid Proceeds" shall mean (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days ; or (d) or a combination of cash and the foregoing securities